Cargando…
The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis
BACKGROUND: Nerves and neurotrophic growth factors are emerging promoters of cancer growth. The precursor for Nerve Growth Factor (proNGF) is overexpressed in thyroid cancer, but its potential role as a clinical biomarker has not been reported. Here we have examined the value of proNGF as a serum an...
Autores principales: | Rowe, Christopher W., Faulkner, Sam, Paul, Jonathan W., Tolosa, Jorge M., Gedye, Craig, Bendinelli, Cino, Wynne, Katie, McGrath, Shaun, Attia, John, Smith, Roger, Hondermarck, Hubert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882079/ https://www.ncbi.nlm.nih.gov/pubmed/31775768 http://dx.doi.org/10.1186/s12902-019-0457-1 |
Ejemplares similares
-
The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables
por: Rowe, Christopher W., et al.
Publicado: (2019) -
ProNGF Expression and Targeting in Glioblastoma Multiforme
por: Marsland, Mark, et al.
Publicado: (2023) -
ProNGF is a potential diagnostic biomarker for thyroid cancer
por: Faulkner, Sam, et al.
Publicado: (2016) -
Expression of NGF/proNGF and Their Receptors TrkA, p75(NTR) and Sortilin in Melanoma
por: Marsland, Mark, et al.
Publicado: (2022) -
Conformational Plasticity of proNGF
por: Paoletti, Francesca, et al.
Publicado: (2011)